PRESS RELEASE DUBLIN, Ohio, Dec site . 17, 2014 — Cardinal Health is seeking tales of innovative, inspirational, passionate medical laboratory specialists in the second year of its urEssential award plan, an award system to recognize medical laboratory experts and their contributions to the field of healthcare. Laboratorians are unsung heroes, working quietly behind the scenes and contributing to care that’s helping people live much longer, healthier lives, said Chris Kerski, senior vice president and general manager of Laboratory Products at Cardinal Health.
CardioDx establishes protection for Corus CAD gene expression test CardioDx, Inc. With this decision, the Corus CAD gene expression test is a covered benefit for a lot more than 40 million now Medicare enrollees in the U.S. The check has been validated in multiple independent patient cohorts clinically, including two prospective, multicenter U.S. Trials, PREDICT and COMPASS. Additionally, a retrospective, multicenter chart review research and the prospective IMPACT trial at Vanderbilt University demonstrated that Corus CAD use yielded significant and relevant adjustments in clinically patient administration decisions in both principal cardiology and care settings. ‘As the Corus CAD test was recognized by TIME Magazine as a high 10 medical breakthrough this year 2010, the entire year the PREDICT validation research was published, fulfilling Medicare reimbursement criteria is currently a major step forward,’ said Eric Topol, M.D., Principal Investigator of the PREDICT trial, Chief Academic Officer at Scripps Professor and Health of Genomics at The Scripps Study Institute.